AstraZeneca Gets Druggists' Antitrust Suit Tossed

Law360, New York (February 26, 2008, 12:00 AM EST) -- Marking a sweeping victory for AstraZeneca, a federal judge ruled Monday that a group of drugstores had failed to prove the pharmaceutical giant violated antitrust law when it put its marketing muscle behind heartburn drug Nexium instead of Prilosec as the latter's patent protection was about to lapse.

Judge Richard W. Roberts of the U.S. District Court for the District of Columbia granted AstraZeneca's motions to dismiss the complaints.

“Plaintiffs have not alleged facts that support an inference that AstraZeneca’s conduct in switching the market from...
To view the full article, register now.